While reduced TGF-β signaling is associated with impaired bone and wound healing [36,37,38,39] its prolonged or enhanced signaling is associated with fibrotic conditions, keloids, hypertrophic scar formation, and chronic wounds [19,35,40]. The gene discussed is TGFB1; the disease is keloid.